BRCA1 and breast cancer: The results show that the risk of developing contralateral breast cancer in women with the BRCA1/2 deleterious mutation was four times greater, however, carriers exposed to radiation underlying radiotherapy for primary breast cancer did not have a significantly higher relative risk of contralateral breast cancer compared to unexposed carriers.